Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Ophthalmological Medicine
Volume 2014, Article ID 682583, 6 pages
http://dx.doi.org/10.1155/2014/682583
Case Report

Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report

1Ophthalmiatrion Athinon, 26 Eleftheriou Venizelou Street, 10672 Athens, Greece
2Eye CU Center, 8 Naiadon Street, 11634 Athens, Greece
31st Department of Ophthalmology, University of Athens, G. Gennimatas Hospital, 154 Mesogeion Street, 11527 Athens, Greece

Received 26 September 2014; Accepted 14 November 2014; Published 23 November 2014

Academic Editor: Maurizio Battaglia Parodi

Copyright © 2014 Panagiotis G. Mitropoulos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Modell and M. Darlison, “Global epidemiology of haemoglobin disorders and derived service indicators,” Bulletin of the World Health Organization, vol. 86, no. 6, pp. 480–487, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Leveziel, F. Lalloum, S. Bastuji-Garin et al., “Sickle-cell retinopathy: retrospective study of 730 patients followed in a referral center,” Journal Francais d'Ophtalmologie, vol. 35, no. 5, pp. 343–347, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. F. Bunn, “Pathogenesis and treatment of sickle cell disease,” The New England Journal of Medicine, vol. 337, no. 11, pp. 762–769, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Elagouz, S. Jyothi, B. Gupta, and S. Sivaprasad, “Sickle cell disease and the eye: old and new concepts,” Survey of Ophthalmology, vol. 55, no. 4, pp. 359–377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. T. B. C. Bonanomi and M. M. Lavezzo, “Sickle cell retinopathy: diagnosis and treatment,” Arquivos Brasileiros de Oftalmologia, vol. 76, no. 5, pp. 320–327, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. P. D. Fox, D. T. Dunn, J. S. Morris, and G. R. Serjeant, “Risk factors for proliferative sickle retinopathy,” British Journal of Ophthalmology, vol. 74, no. 3, pp. 172–176, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. M. F. Goldberg, S. Charache, and I. Acacio, “Ophthalmologic manifestations of sickle cell thalassemia,” Archives of Internal Medicine, vol. 128, no. 1, pp. 33–39, 1971. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Shweiki, A. Itin, D. Soffer, and E. Keshet, “Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis,” Nature, vol. 359, no. 6398, pp. 843–845, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. J. W. Miller, “Vascular endothelial growth factor and ocular neovascularization,” American Journal of Pathology, vol. 151, no. 1, pp. 13–23, 1997. View at Google Scholar · View at Scopus
  10. M. F. Goldberg, “Retinal neovascularization in sickle cell retinopathy,” Transactions: American Academy of Ophthalmology and Otolaryngology, vol. 83, no. 3, pp. OP409–OP431, 1977. View at Google Scholar · View at Scopus
  11. M. Waisbourd, M. Goldstein, and A. Loewenstein, “Treatment of diabetic retinopathy with anti-VEGF drugs,” Acta Ophthalmologica, vol. 89, no. 3, pp. 203–207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. I. P. Chatziralli, A. Jaulim, V. G. Peponis, P. G. Mitropoulos, and M. M. Moschos, “Branch retinal vein occlusion: treatment modalities: An update of the literature,” Seminars in Ophthalmology, vol. 29, no. 2, pp. 85–107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. M. Castellanos, S. Schwartz, G. García-Aguirre, and H. Quiroz-Mercado, “Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity,” British Journal of Ophthalmology, vol. 97, no. 7, pp. 816–819, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. Gaillard, A. Mataftsi, A. Balmer, S. Houghton, and F. L. Munier, “Ranibizumab in the management of advanced coats disease stages 3B and 4: long-term outcomes,” Retina, vol. 34, no. 11, pp. 2275–2281, 2014. View at Publisher · View at Google Scholar
  15. D. S. Dhoot and P. K. Kaiser, “Ranibizumab for age-related macular degeneration,” Expert Opinion on Biological Therapy, vol. 12, no. 3, pp. 371–381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Wang and Y. Chen, “Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization secondary to pathologic myopia: systematic review and meta-analysis,” Retina, vol. 33, no. 7, pp. 1375–1392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. L. E. Lantry, “Ranibizumab, a mAb against VEGF-A for the potential treatment of age-related macular degeneration and other ocular complications,” Current Opinion in Molecular Therapeutics, vol. 9, no. 6, pp. 592–602, 2007. View at Google Scholar · View at Scopus
  18. M. F. Goldberg, “Classification and pathogenesis of proliferative sickle retinopathy,” The American Journal of Ophthalmology, vol. 71, no. 3, pp. 649–665, 1971. View at Publisher · View at Google Scholar · View at Scopus
  19. R. C. Siqueira, R. A. Costa, I. U. Scott, L. P. Cintra, and R. Jorge, “Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy,” Acta Ophthalmologica Scandinavica, vol. 84, no. 6, pp. 834–835, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Shaikh, “Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy,” Indian Journal of Ophthalmology, vol. 56, no. 3, p. 259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. O. E. Babalola, “Intravitreal bevacizumab (Avastin) associated with secondary hyphaema in a case of proliferative sickle cell retinopathy,” BMJ Case Reports, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Brasileiro, T. T. Martins, S. B. Campos et al., “Macular and peripapillary spectral domain optical coherence tomography changes in sickle cell retinopathy,” Retina. In press.